Evidence map›Paper›PMID 23908768›Full record

ArticleeLife2013

Structural analysis of autoinhibition in the Ras-specific exchange factor RasGRP1.

Jeffrey S Iwig, Yvonne Vercoulen, Rahul Das, Tiago Barros, Andre Limnander, Yan Che, Jeffrey G Pelton, David E Wemmer, Jeroen P Roose, John Kuriyan

Open access · goldAbstract read
In one paragraph

Article in eLife, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 87 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Modeling platelet P2YBiophysical journal · 2025
    Article
  5. Article
  6. Acta biochimica et biophysica Sinica · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Regulation of the Small GTPase Ras and Its Relevance to Human Disease.Methods in molecular biology (Clifton, N.J.) · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Atypical KRASCancer discovery · 2020
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jeffrey S IwigDepartment of Molecular and Cell Biology , University of California, Berkeley , Berkeley , United States ; California Institute for Quantitative Biosciences , University of California, Berkeley , Berkeley , United States.
Yvonne Vercoulen
Rahul Das
Tiago Barros
Andre Limnander
Yan Che
Jeffrey G Pelton
David E Wemmer
Jeroen P Roose
John Kuriyan
University of California, Berkeley · USQB3 · USUniversity of California, San Francisco · US

Funding

Understand the metabolic fitness of naïve T cellsP01AI091580 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JEROEN ROOSE · 2011 to 2026
$31.1M
TRANS-NETWORK PROJECTSU54CA143874 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI VAN OUDENAARDEN, ALEXANDER · 2009 to 2013
$15.1M
Mechanistic Studies of Ras-MAPK Signals: Specialzed Cues for the T cell Lineage?R56AI095292 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROOSE, JEROEN · 2011 to 2011
$258k
Differential regulation of Ras nucleotide exchange factorsF32GM095149 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI IWIG, JEFFREY SCOTT · 2010 to 2012
$146k
Modulation of B cell tolerance checkpoints by distinct Ras/Erk PathwaysR03AR062783 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIMNANDER, ANDRE · 2013 to 2014
$139k
NCI NIH HHS U54CA143874NIAID NIH HHS P01 AI091580NIAID NIH HHS R56 AI095292NIAID NIH HHS R56-AI095292NIAMS NIH HHS R03 AR062783NIAMS NIH HHS R03AR062783NIGMS NIH HHS 5F32GM095149-03
6 · The paper itself

Abstract

RasGRP1 and SOS are Ras-specific nucleotide exchange factors that have distinct roles in lymphocyte development. RasGRP1 is important in some cancers and autoimmune diseases but, in contrast to SOS, its regulatory mechanisms are poorly understood. Activating signals lead to the membrane recruitment of RasGRP1 and Ras engagement, but it is unclear how interactions between RasGRP1 and Ras are suppressed in the absence of such signals. We present a crystal structure of a fragment of RasGRP1 in which the Ras-binding site is blocked by an interdomain linker and the membrane-interaction surface of RasGRP1 is hidden within a dimerization interface that may be stabilized by the C-terminal oligomerization domain. NMR data demonstrate that calcium binding to the regulatory module generates substantial conformational changes that are incompatible with the inactive assembly. These features allow RasGRP1 to be maintained in an inactive state that is poised for activation by calcium and membrane-localization signals. DOI:http://dx.doi.org/10.7554/eLife.00813.001.

Indexed as

Amino Acid SequenceBinding SitesCalciumCrystallography, X-RayDNA-Binding ProteinsGuanine Nucleotide Exchange FactorsHumansModels, MolecularMolecular Sequence DataNuclear Magnetic Resonance, BiomolecularProtein ConformationRecombinant ProteinsSequence Homology, Amino AcidCalciumDNA-Binding ProteinsGuanine Nucleotide Exchange FactorsRASGRP1 protein, humanRecombinant Proteinscell signalingdiacylglycerolHumannucleotide exchange factor

Identifiers

PMID23908768
PMCPMC3728621
OpenAlexW2073209241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.